Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SVA

Sernova (SVA)

Sernova Corp
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:SVA
DateTimeSourceHeadlineSymbolCompany
03/06/202201:00PR Newswire (Canada)Sernova Opens the MarketTSXV:SVASernova Corp
11/01/202201:48PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
11/01/202201:46PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
11/01/202201:44PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
11/01/202201:41PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
05/02/202102:01PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
05/02/202101:58PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
05/02/202101:44PR Newswire (Canada)Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 MillionTSXV:SVASernova Corp
05/02/202101:38PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
05/02/202101:36PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
04/02/202109:20PR Newswire (Canada)Sernova Corp. Announces C$10 Million Bought Deal Offering of UnitsTSXV:SVASernova Corp
16/01/202106:48PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
16/01/202106:45PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
16/01/202106:30PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
16/01/202106:27PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
19/06/202002:58InvestorsHub NewsWirePURA SVA - Health Stocks Exhibit Healthy News, Robust Share HikesTSXV:SVASernova Corp
24/10/201922:30PR Newswire (Canada)Sernova Announces Biotech Veteran as New Chief Financial OfficerTSXV:SVASernova Corp
17/10/201903:55InvestorsHub NewsWireSernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-ATSXV:SVASernova Corp
12/04/201902:14InvestorsHub NewsWireSernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical StudyTSXV:SVASernova Corp
06/07/201800:50InvestorsHub NewsWireSernova Initiates Patient Screening and Recruitment for its US Clinical Trial for DiabetesTSXV:SVASernova Corp
23/02/201800:35InvestorsHub NewsWireSernova's Cell Pouch Regenerative Medicine Clinical Trial for Type 1 Diabetes Supported with CGM SystemsTSXV:SVASernova Corp
12/12/201701:03PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
12/12/201701:02PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
11/12/201723:56InvestorsHub NewsWireSernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 DiabetesTSXV:SVASernova Corp
09/12/201706:20PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
09/12/201706:19PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
15/07/201420:00Marketwired CanadaSernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of DiabetesTSXV:SVASernova Corp
24/06/201420:00MarketwiredSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
24/06/201420:00Marketwired CanadaSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
20/06/201420:00MarketwiredSernova's CEO Dr. Philip Toleikis Featured on BNNTSXV:SVASernova Corp
 Showing the most relevant articles for your search:TSXV:SVA